2016
DOI: 10.2337/db16-0248
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the Pro-Oxidant PKCβII-p66Shc Signaling Pathway Contributes to Pericyte Dysfunction in Skeletal Muscles of Patients With Diabetes With Critical Limb Ischemia

Abstract: General rightsThis document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms AbstractCritical limb ischemia (CLI), foot ulcers, former amputation and impaired regeneration are independent risk factors for limb amputation in diabetic subjects. The present work investigates whether and by which mechanism diabetes negatively impacts on functional properties of m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
51
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 48 publications
(55 citation statements)
references
References 50 publications
4
51
0
Order By: Relevance
“…However, alterations in p66shc expression/phosphorylation occur in pathological conditions in humans, such as in muscular pericytes of diabetic patients (Vono et al, 2016), in peripheral blood monocytes and renal tissue biopsies of patients with diabetic nephropathy (Xu et al, 2016), and also in peripheral blood monocytes of patients with acute coronary syndrome, but not with stable coronary artery disease (Franzeck et al, 2012). Since such risk factors and co-morbidities may abrogate the cardioprotection by preconditioning (Ferdinandy et al, 2014), it remains to be elucidated whether p66shc contributes toward cardioprotection under pathological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…However, alterations in p66shc expression/phosphorylation occur in pathological conditions in humans, such as in muscular pericytes of diabetic patients (Vono et al, 2016), in peripheral blood monocytes and renal tissue biopsies of patients with diabetic nephropathy (Xu et al, 2016), and also in peripheral blood monocytes of patients with acute coronary syndrome, but not with stable coronary artery disease (Franzeck et al, 2012). Since such risk factors and co-morbidities may abrogate the cardioprotection by preconditioning (Ferdinandy et al, 2014), it remains to be elucidated whether p66shc contributes toward cardioprotection under pathological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…It was proved that MSCs exhibit a surface marker profile +ve for CD44 (31). It was added that diabetes negatively impacts on functional properties of tissue resident SCs with consequent defective regeneration (32).…”
Section: Discussionmentioning
confidence: 99%
“…hMSCs were isolated from skeletal muscle tissue using a protocol that includes mechanical mincing, enzymatic digestion with type II collagenase, filtration, and selection of the colonies on plastic surface at low confluence (Sacchetti et al, 2016;Vono et al, 2016). Briefly, human skeletal muscle biopsies are finely minced with a surgical knife and collected in a solution of collagenase type II (100 U/ml in PBS Ca2+/ Mg2+), subsequently left to incubate in a thermal shaker for 45 minutes at 37 °C.…”
Section: Isolation Of Mesenchymal Stem Cells From Muscle Biopsies Andmentioning
confidence: 99%